Brunswick Corporation filings document the public-company reporting of a marine recreation manufacturer with common stock and listed senior notes. Form 8-K reports include quarterly and annual earnings releases, non-GAAP financial measures used in management reporting, dividend-related and other material events, and debt-capital actions involving senior notes.
Proxy materials cover governance, shareholder voting matters, capital-structure disclosure, and operating and financial results. Other filings in the record document note tender offers, redemptions, and exchange notifications, including the removal from listing and registration of a senior note class.
Brunswick Corp director Lauren Patricia Flaherty reported a grant of 562 deferred shares of common stock on July 31, 2026 at $79 per share. The deferred shares are held in a director deferred account and will be distributed in predetermined installments after she ceases serving as director.
Following this award, her direct beneficial holdings total 18,247 shares, including 91 shares acquired through dividend reinvestments through June 2026.
Brunswick Corp director Reginald Fils-Aime reported a compensation-related acquisition of 601 shares of Common Stock on 2026-07-31, coded as a grant, award, or other acquisition at 79.0000 per share. Following this grant, his directly owned Brunswick common stock holdings total 12,052 shares.
Brunswick Corp director Roger Wood received a grant of 585 deferred common shares on July 31, 2026 at $79 per share. The shares were credited to his director deferred account and will be distributed in predetermined installments after he leaves the board. Following this award, he beneficially holds 68,610 shares, including 352 shares acquired through dividend reinvestments through June 2026.
BRUNSWICK CORP director David C. Everitt received a grant of 740 deferred shares of common stock on 2026-07-31 at $79 per share. These deferred shares are deposited in his director deferred account and will be distributed in predetermined installments after he ceases being a director, bringing his direct holdings to 39,908 shares, including 203 shares acquired through dividend reinvestments through June 2026.
Brunswick Corp director David V. Singer reported a grant, award, or other acquisition of 1,046 shares of common stock on 2026-07-31 at $79.00 per share. Following this award, he directly holds 37,546 shares, including 437 deferred shares credited to a deferred account that will be distributed in predetermined installments after he ceases serving as a director. Beneficial holdings also include 140 shares acquired through dividend reinvestment through June 2026, and an additional 19,789 shares are reported as indirectly owned via the Barbara B Singer 2014 Irrevocable Trust.
Brunswick Corp director MaryAnn Wright reported a grant of 581 shares of common stock on July 31, 2026, at $79 per share. These deferred shares were deposited into her director deferred account and will be distributed in predetermined installments after she leaves the board. Following this award, she beneficially holds 11,764 shares, including 58 shares acquired through dividend reinvestment through June 2026.
Brunswick Corp director Joseph W. McClanathan received a grant of 562 shares of common stock on July 31, 2026 at a reference price of $79.00 per share. After this award, he beneficially owns 28,238 shares, including 114 shares acquired through dividend reinvestment through June 2026.
WHISLER J STEVEN reported acquisition or exercise transactions in this Form 4 filing.
BRUNSWICK CORP director J Steven Whisler received a grant of 1,026 deferred common shares on July 31, 2026 at $79.00 per share, credited to his director deferred account. These deferred shares will be automatically distributed in predetermined installments after he ceases being a director. Following this award he beneficially owns 100,003 common shares directly, including 481 from dividend reinvestments through June 2026, and 1,000 shares indirectly through a Family Trust.
Brunswick Corp director Nancy E. Cooper reported two Common Stock transactions. On July 31, 2026, she acquired 589 shares at $79.00 per share through a grant or award. On August 3, 2026, she sold 206 shares at $78.45 per share in an open market or private transaction. These trades are reported as made under a Rule 10b5-1 trading plan.